Evidence map›Paper›PMID 40836018›Full record

ArticleEuropean radiology2026

Attention-based deep learning network for predicting World Health Organization meningioma grade and Ki-67 expression based on magnetic resonance imaging.

Xing Cheng, Huaning Li, Chen Li, Jintan Li, Zijie Liu, Xiao Fan, Chenfei Lu, Kefan Song, Zhiyan Shen, Zhichao Wang and 6 more

Abstract read
In one paragraph

Article in European radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Xing Cheng *Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Huaning Li *Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Chen Li *Department of Neurosurgery, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing, China.
Jintan Li *Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Zijie LiuThe First Clinical School of Nanjing Medical University, Nanjing, China.
Xiao FanDepartment of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Chenfei LuDepartment of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Kefan SongDepartment of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Zhiyan ShenDepartment of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Zhichao WangDepartment of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Qing YangDepartment of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Junxia ZhangDepartment of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Jianxing YinDepartment of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Chunfa QianDepartment of Neurosurgery, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing, China. njnkqcf@njmu.edu.cn.
Yongping YouDepartment of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China. yypl9@njmu.edu.cn.
Xiefeng WangDepartment of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China. xiefeng@njmu.edu.cn.ORCID http://orcid.org/0000-0001-7031-5532

Funding

Jiangsu Province Capability Improvement Project through Science, Technology and Education ZDXK202225National Natural Science Foundation of China 82172667National Natural Science Foundation of China 82272651
6 · The paper itself

Abstract

objectivesPreoperative assessment of World Health Organization (WHO) meningioma grading and Ki-67 expression is crucial for treatment strategies. We aimed to develop a fully automated attention-based deep learning network to predict WHO meningioma grading and Ki-67 expression. MATERIALS AND

methodsThis retrospective study included 952 meningioma patients, divided into training (n = 542), internal validation (n = 96), and external test sets (n = 314). For each task, clinical, radiomics, and deep learning models were compared. We used no-new-Unet (nn-Unet) models to construct the segmentation network, followed by four classification models using ResNet50 or Swin Transformer architectures with 2D or 2.5D input strategies. All deep learning models incorporated attention mechanisms.

resultsBoth the segmentation and 2.5D classification models demonstrated robust performance on the external test set. The segmentation network achieved Dice coefficients of 0.98 (0.97-0.99) and 0.87 (0.83-0.91) for brain parenchyma and tumour segmentation. For predicting meningioma grade, the 2.5D ResNet50 achieved the highest area under the curve (AUC) of 0.90 (0.85-0.93), significantly outperforming the clinical (AUC = 0.77 [0.70-0.83], p < 0.001) and radiomics models (AUC = 0.80 [0.75-0.85], p < 0.001). For Ki-67 expression prediction, the 2.5D Swin Transformer achieved the highest AUC of 0.89 (0.85-0.93), outperforming both the clinical (AUC = 0.76 [0.71-0.81], p < 0.001) and radiomics models (AUC = 0.82 [0.77-0.86], p = 0.002).

conclusionOur automated deep learning network demonstrated superior performance. This novel network could support more precise treatment planning for meningioma patients. KEY POINTS: Question Can artificial intelligence accurately assess meningioma WHO grade and Ki-67 expression from preoperative MRI to guide personalised treatment and follow-up strategies? Findings The attention-enhanced nn-Unet segmentation achieved high accuracy, while 2.5D deep learning models with attention mechanisms achieved accurate prediction of grades and Ki-67. Clinical relevance Our fully automated 2.5D deep learning model, enhanced with attention mechanisms, accurately predicts WHO grades and Ki-67 expression levels in meningiomas, offering a robust, objective, and non-invasive solution to support clinical diagnosis and optimise treatment planning.

Indexed as

Deep LearningKi-67 AntigenMagnetic Resonance ImagingMeningeal NeoplasmsMeningiomaAdultAgedFemaleHumansImage Interpretation, Computer-AssistedMaleMiddle AgedNeoplasm GradingRetrospective StudiesWorld Health OrganizationKi-67 AntigenAttention mechanismsDeep learningKi-67 expressionMagnetic resonance imagingMeningioma

Identifiers

PMID40836018
PMCPMC13035881

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.